The draft guidance, which is touted as a way to reduce the cost and time-associated burden of biosimilar development, has ...

Researchers at the University at Buffalo have enhanced a computationally efficient technique referred to as the truncated Wigner approximation (TWA), a type of physics shortcut that simplifies quantum ...

What if you could transform the way you tackle complex tasks, making them not only manageable but seamless? Imagine having a single, organized hub where your ideas, files, and instructions come ...

The PREVENT tool — the newest cardiovascular risk calculator — makes individual dialogue between doctor and patient more ...

About one-third of all drugs approved by the Food and Drug Administration target the largest family of cell membrane ...

Easier KYC access could open investment opportunities for millions of NRIs worldwide SEBI Chairperson Tuhin Kanta Pandey said the regulator is working to roll out secure, remote KYC verification for ...

What if you could turn a dense, jargon-filled research paper or a lengthy market report into a crisp, visually engaging video in just minutes? With the latest update to Google’s NotebookLM, that’s no ...

There is a new calculator that shows how President Donald Trump’s “big, beautiful” law will affect your 2026 tax bill, and how much additional take-home pay you’ll be getting. The calculator, from the ...

Developers of biosimilars, medicines that are near-identical copies of biologic drugs, will no longer be required to conduct clinical trials to prove effectiveness.

The deal unites two of the most recognisable names in the analytics and AI infrastructure world. George Fraser, CEO of Fivetran (pictured), will lead the combined company, while dbt Labs founder and ...

The FDA today unveiled a plan to accelerate development of biosimilars in hopes of significantly reducing drug costs in the United States.The agency issued draft guidance that would simplify the study ...